The Burden of Lassa Fever among Nigerian Health Workers: A Ten-Year Review (2015-2025) of the literature.

workers (HCWs) to nosocomial infection, morbidity, and mortality. Objective: To synthesize ten years of evidence on LF burden among Nigerian HCWs, quantify HCW infections relative to confirmed national cases where data permit, and summarize clinical outcomes and key occupational risk factors.
Methods: A narrative review was conducted using peer-reviewed studies, WHO outbreak reports, and the Nigeria Centre for Disease Control and Prevention (NCDC) Lassa fever situation reports. Descriptive statistics were extracted. Where national totals were available, we calculated HCW infection proportion among confirmed cases (HCW/confirmed), with 95% confidence intervals (Wilson method). A log-linear trend model estimated annual percent change in HCW proportion (2019, 2020, 2022–2025; excluding partial year 2021).
Results: In early 2016, the WHO reported 10 HCWs infected and 2 deaths in Nigeria (Aug 2015–May 2016). [1] During the 2016/2017 season, Nigeria recorded 788 suspected cases, 247 confirmed cases, and 117 deaths by epi week 34, with an AAR emphasizing IPC strengthening.[2] During the 2018 outbreak, a two-treatment-center HCW series documented 21 laboratory-confirmed HCW infections with CFR 23.8%, delayed testing (median 12 days), and IPC gaps.[3] In 2019, a national investigation described 19 HCW infections (2 deaths; CFR 10.5%), most linked to clinical care exposures and inadequate IPC training. [4] In national surveillance reports, HCW infections represented 2.1–5.3 per 100 confirmed cases (2019–2025), with no significant linear trend (annual percent change) 2.77%; 95% CI −22.42 to 21.87; p=0.75; calculated) [4–10]
Conclusion: LF remains a sustained occupational hazard for Nigerian HCWs. Preventable exposure, especially in outpatient/emergency and procedural settings, persists. System-level IPC programs, early triage and suspicion, reliable PPE supply, and rapid diagnostics are essential to reduce HCW infections and deaths.

Lassa fever; healthcare workers; Nigeria; occupational exposure

1. World Health Organization Regional Office for Africa. Disease outbreak – Lassa fever – Nigeria (27 May 2016). 2016 [cited 2026 Mar 2]. Available from: https://www.afro.who.int/health-topics/lassa-fever/outbreak/27-may-2016-nigeria [afro.who.int] [Google Scholar] [Crossref]

2. Nigeria Centre for Disease Control; World Health Organization. 2016/2017 Lassa Fever Outbreak After Action Review (AAR), Nigeria (Aug 2017). 2017 [cited 2026 Mar 2]. Available from: https://extranet.who.int/sph/sites/default/files/%28EN-Nigeria%29%20-%20Lassa%20Fever%20AAR_2017.pdf [extranet.who.int] [Google Scholar] [Crossref]

3. Ogbaini Emovon E, Erah F, Osagiede EF, et al. Lassa fever infection among healthcare workers during the 2018 outbreak in Nigeria. Int J Occup Safety Health. 2023;13(3):272 281. Available from: https://www.researchgate.net/publication/372130954_Lassa_Fever_Infection_among_Healthcare_Workers_during_the_2018_Outbreak_in_Nigeria/fulltext/64a8af2395bbbe0c6e1e4d54/Lassa-Fever-Infection-among-Healthcare-Workers-during-the-2018-Outbreak-in-Nigeria.pdf [ncdc.gov.ng] [Google Scholar] [Crossref]

4. Saleh M, Dan Nwafor C, Ipadeola O, et al. Exposure incidents and outcome of Lassa fever virus infection among healthcare workers in Nigeria, 2019. J Infect Dis Epidemiol. 2019. Available from: https://clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-6-168.php [ncdc.gov.ng] [Google Scholar] [Crossref]

5. Nigeria Centre for Disease Control. Lassa fever situation report, Epi Week 52 (21–27 Dec 2020). 2020 [cited 2026 Mar 2]. Available from: https://ncdc.gov.ng/themes/common/files/sitreps/e9cf6841a83cdfdef7d73200813b9126.pdf [ncdc.gov.ng] [Google Scholar] [Crossref]

6. Nigeria Centre for Disease Control. Lassa fever situation report, Epi Week 39 (27 Sep–3 Oct 2021). 2021 [cited 2026 Mar 2]. Available from: https://ncdc.gov.ng/themes/common/files/sitreps/842332eefa12f791b84fa44bc0f5e875.pdf [zadmin.ncdc.gov.ng] [Google Scholar] [Crossref]

7. Nigeria Centre for Disease Control and Prevention. Lassa fever situation report, Epi Week 50 (12–18 Dec 2022). 2022 [cited 2026 Mar 2]. Available from: https://zadmin.ncdc.gov.ng/themes/common/files/sitreps/1bffa39cdea17880ccfac3684a1428dc.pdf [ncdc.gov.ng] [Google Scholar] [Crossref]

8. World Health Organization. Lassa Fever – Nigeria (Disease Outbreak News, 14 Feb 2022). 2022 [cited 2026 Mar 2]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/lassa-fever---nigeria [Google Scholar] [Crossref]

9. Nigeria Centre for Disease Control and Prevention. Lassa Fever Situation Report, Epi Week 52 (25–31 Dec 2023). 2023 [cited 2026 Mar 2]. Available from: https://ncdc.gov.ng/themes/common/files/sitreps/60b4a539bd9b9852ac1a5059ec0f3433.pdf [extranet.who.int] [Google Scholar] [Crossref]

10. Nigeria Centre for Disease Control and Prevention. Lassa Fever Situation Report, Epi Week 52 (23–29 Dec 2024). 2024 [cited 2026 Mar 2]. Available from: https://www.ncdc.gov.ng/themes/common/files/sitreps/a45a720bd6ddd1e75a5a3e7e6195e412.pdf [ncdc.gov.ng] [Google Scholar] [Crossref]

11. Nigeria Centre for Disease Control and Prevention. Lassa Fever Situation Report, Epi Week 52 (22–28 Dec 2025). 2025 [cited 2026 Mar 2]. Available from: https://www.ncdc.gov.ng/themes/common/files/sitreps/04beb529df54f4ceb99ac291842640b4.pdf [afro.who.int] [Google Scholar] [Crossref]

12. Ojo OB. Epidemiology of Lassa fever in Nigeria, 2015–2025: a descriptive study. 2025 [cited 2026 Mar 2]. Available from: https://directivepublications.org/joid/articles/Epidemiology-of-Lassa-Fever-in-Nigeria-2015-2025-A-Descriptive-Study.pdf [Google Scholar] [Crossref]

13. Adepoju P. Lassa fever in Nigeria. Lancet Microbe. 2024;5(10):100960. Available from: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247%2824%2900213-1/fulltext [Google Scholar] [Crossref]

14. Adewumi IP, Babatope AE, Adepoju KO, et al. Trends, public health implications, and emerging concerns of Lassa fever in Ondo state, Nigeria (2020–2024). Discover Public Health. 2025. Available from: https://link.springer.com/content/pdf/10.1186/s12982-025-00811-3.pdf [Google Scholar] [Crossref]

15. Wada YH, Ogunyinka IA, Yusuff KB, et al. Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria. PLoS Negl Trop Dis. 2022;16:e0010259. Available from: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010259 [extranet.who.int] [Google Scholar] [Crossref]

16. Ogboghodo EO, Ehinze ES, Osaigbovo II, et al. Institutional response to fatal Lassa fever in a healthcare worker in Benin City, Nigeria: a case report. J Med Biomed Res. 2024? (as hosted). Available from: https://www.ajol.info/index.php/jmbr/article/download/297657/279932 [iosrjournals.org] [Google Scholar] [Crossref]

17. Akindokun SS, Adeleye OO, Olorunlowu DR. The socioeconomic impact of Lassa fever in Nigeria. Discover Public Health. 2024;21:133. Available from: https://link.springer.com/article/10.1186/s12982-024-00265-z [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review